Status:
UNKNOWN
Optimal dRug Eluting steNts Implantation Guided By Intravascular Ultrasound and Optical coheRence tomoGraphy ORENBURG
Lead Sponsor:
The Orenburg Regional Clinical Hospital
Conditions:
Coronary Artery Disease
Coronary Disease
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The objective of this research is to assess the clinical results of implantation of different drug eluting stents under "aggressive" intravascular ultrasound (IVUS) guided all the way up to 24 months ...
Detailed Description
1000 consecutive patients are planned to be included who will underwent endovascular treatment answering for the inclusion criteria and having given informed consent to the inclusion in the study. Cr...
Eligibility Criteria
Inclusion
- de novo lesion,
- the diameter of a vessel is not less than 2,75 mm,
- the length of lesion not more than 60 mm,
- stenosis is more than 60 %,
- possibility of a covering by no more than 2 stents,
- there is no need in stenting of side branch (including left main coronary artery).
Exclusion
- in-stent restenosis,
- saphenous vein grafts,
- the diameter of a vessel is less than 2,75 mm,
- the length of lesion more than 60 mm,
- there is a need in stenting of side branch (including left main coronary artery),
- impossibility of long antiplatelet therapy,
- impossibility of an appearance for control research
Key Trial Info
Start Date :
March 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2016
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT01917201
Start Date
March 1 2012
End Date
December 1 2016
Last Update
October 28 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The State Budgetary Establishment of Health "the Orenburg Regional Clinical Hospital"
Orenburg, Orenburg Oblast, Russia, 460018